|
GHITM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.13979961422228E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.87156973147285E-12 |
| Normal-vs-Stage2 |
4.350700E-04 |
| Normal-vs-Stage3 |
2.31880000001183E-06 |
| Normal-vs-Stage4 |
2.708400E-02 |
| Stage1-vs-Stage2 |
3.572400E-01 |
| Stage1-vs-Stage3 |
8.206800E-01 |
| Stage1-vs-Stage4 |
4.252400E-01 |
| Stage2-vs-Stage3 |
5.875800E-01 |
| Stage2-vs-Stage4 |
9.323600E-01 |
| Stage3-vs-Stage4 |
6.117600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.04034575293599E-12 |
| Normal-vs-AfricanAmerican |
3.68399977190847E-10 |
| Normal-vs-Asian |
5.348200E-01 |
| Caucasian-vs-AfricanAmerican |
7.331600E-01 |
| Caucasian-vs-Asian |
4.809800E-01 |
| AfricanAmerican-vs-Asian |
5.144800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.38697950294409E-13 |
| Normal-vs-Female |
1.30160000000323E-07 |
| Male-vs-Female |
1.771810E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.76219999598248E-08 |
| Normal-vs-Extreme_Weight |
1.62925228863742E-12 |
| Normal-vs-Obese |
8.84069484285988E-11 |
| Normal-vs-Extreme_Obese |
6.521900E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.513000E-01 |
| Normal_Weight-vs-Obese |
9.473800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.641400E-01 |
| Extreme_Weight-vs-Obese |
3.856400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.502400E-01 |
| Obese-vs-Extreme_Obese |
3.717000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.232200E-04 |
| Normal-vs-Age(41-60Yrs) |
2.50133247448048E-13 |
| Normal-vs-Age(61-80Yrs) |
2.20550244733886E-11 |
| Normal-vs-Age(81-100Yrs) |
1.924270E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.235200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.903000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.757000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.202800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.912600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.773800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63213886850144E-12 |
| Normal-VS-Type2 PRCC |
2.46749999999185E-06 |
| Normal-VS-KIRP CIMP |
6.656300E-02 |
| Normal-VS-Unclassified PRCC |
9.30859833658815E-11 |
| Type1 PRCC-VS-Type2 PRCC |
5.596500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.838200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.912000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.532200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.159700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.985600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.35229988002573E-10 |
| Normal-vs-N1 |
1.10119999996439E-06 |
| Normal-vs-N2 |
9.767700E-04 |
| N0-vs-N1 |
5.813000E-01 |
| N0-vs-N2 |
8.272000E-01 |
| N1-vs-N2 |
9.656400E-01 |
|
|
